Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes.
We recently reported that CD47 (integrin-associated protein) on sickle red blood cells (SS RBCs) activates G-protein-dependent signaling, which promotes cell adhesion to immobilized thrombospondin (TSP) under relevant shear stress. These data suggested that signal transduction in SS RBCs may contribute to the vaso-occlusive pathology observed in sickle cell disease. However, the CD47-activated SS RBC adhesion receptor(s) that mediated adhesion to immobilized TSP remained unknown. Here we demonstrate that the alpha4beta1 integrin (VLA-4) is the receptor that mediates CD47-stimulated SS RBC adhesion to immobilized TSP. This adhesion requires both the N-terminal heparin-binding domain and the RGD site of TSP. CD47 signaling induces an "inside-out" activation of alpha4beta1 on SS RBCs as indicated by an RGD-dependent interaction of this integrin with soluble, plasma fibronectin. However, CD47 engagement also induces an alpha4beta1-mediated, RGD-independent adhesion of SS RBCs to immobilized vascular cell adhesion molecule-1 (VCAM-1). CD47 signaling in SS RBCs appears to be independent of large scale changes in cAMP formation but nonetheless promotes alpha4beta1-mediated adhesion via a protein kinase A-dependent, serine phosphorylation of the alpha4 cytoplasmic domain. CD47-activated SS RBC adhesion absolutely requires the Src family tyrosine kinases and is also enhanced by treatment of SS RBCs with low concentrations of cytochalasin D, which may release alpha4beta1 from cytoskeletal restraints. In addition, CD47 co-immunoprecipitates with alpha4beta1 in a sickle reticulocyte-enriched fraction of SS RBCs. These studies therefore identify the alpha4beta1 integrin on SS RBCs as a CD47-activated receptor for TSP, VCAM-1, and plasma fibronectin, revealing novel binding characteristics of this integrin.
Department of Pharmacology, University of North Carolina at Chapel Hill, 27599-7365, USA.
Julia E
JE
Brittain
Jaewon
J
Han
Kenneth I
KI
Ataga
Eugene P
EP
Orringer
Leslie V
LV
Parise
D000755:Anemia, Sickle Cell / Q000097:blood*; D015703:Antigens, CD / Q000737:chemistry / Q000378:metabolism*; D015153:Blotting, Western; D051928:CD47 Antigen; D002448:Cell Adhesion; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D015638:Cytochalasin D / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D003599:Cytoskeleton / Q000378:metabolism; D005353:Fibronectins / Q000097:blood / Q000378:metabolism; D006801:Humans; D047468:Immunoprecipitation; D039041:Integrin alpha4beta1 / Q000378:metabolism*; D009842:Oligopeptides / Q000737:chemistry; D010455:Peptides / Q000737:chemistry; D010766:Phosphorylation; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry; D012156:Reticulocytes / Q000378:metabolism*; D015398:Signal Transduction; D013347:Subcellular Fractions / Q000378:metabolism; D019699:Thrombospondins / Q000378:metabolism; D013997:Time Factors; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
D015703:Antigens, CD; D051928:CD47 Antigen; C497894:CD47 protein, human; D005353:Fibronectins; D039041:Integrin alpha4beta1; D009842:Oligopeptides; D010455:Peptides; D011994:Recombinant Proteins; D019699:Thrombospondins; D019010:Vascular Cell Adhesion Molecule-1; D015638:Cytochalasin D; C047981:arginyl-glycyl-aspartic acid; D017868:Cyclic AMP-Dependent Protein Kinases